BVS vs MELI · rev $573.3M vs P/E 43, rev $20.78B
Bioventus Inc (BVS) versus MercadoLibre Inc. (MELI) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
MercadoLibre Inc. (MELI) is a internet retail company listed on NASDAQ.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported MELI revenue for 2024-12-31 was $20.78B. Net income was $1.91B. Revenue was up 387.6% from 2023-12-31 to 2024-12-31. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
BVS currently screens at market cap $495.1M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
Not investment advice. Open the BVS and MELI stock pages for the full models.
Not investment advice.